当前位置:
X-MOL 学术
›
Annu. Rev. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome.
Annual Review of Medicine ( IF 10.5 ) Pub Date : 2020-01-27 , DOI: 10.1146/annurev-med-053117-123246 Zubaidah Nor Hanipah 1 , Philip R Schauer 2
Annual Review of Medicine ( IF 10.5 ) Pub Date : 2020-01-27 , DOI: 10.1146/annurev-med-053117-123246 Zubaidah Nor Hanipah 1 , Philip R Schauer 2
Affiliation
Metabolic surgery is increasingly becoming recognized as a more effective treatment for patients with type 2 diabetes (T2D) and obesity as compared to lifestyle modification and medical management alone. Both observational studies and clinical trials have shown metabolic surgery to result in sustained weight loss (20-30%), T2D remission rates ranging from 23% to 60%, and improvement in cardiovascular risk factors such as hypertension and dyslipidemia. Metabolic surgery is cost-effective and relatively safe, with perioperative risks and mortality comparable to low-risk procedures such as cholecystectomy, hysterectomy, and appendectomy. International diabetes and medical organizations have endorsed metabolic surgery as a standard treatment for T2D with obesity.
中文翻译:
减肥手术作为2型糖尿病/代谢综合征的长期治疗。
与仅改变生活方式和药物治疗相比,代谢外科手术已日益被认为是2型糖尿病(T2D)和肥胖症患者的更有效治疗方法。观察性研究和临床试验均显示,代谢外科手术可导致持续的体重减轻(20-30%),T2D缓解率从23%到60%不等,并改善心血管疾病的危险因素,例如高血压和血脂异常。代谢外科手术具有成本效益且相对安全,围手术期的风险和死亡率可与低风险手术(如胆囊切除术,子宫切除术和阑尾切除术)相媲美。国际糖尿病和医疗组织已批准将代谢外科手术作为肥胖症T2D的标准治疗方法。
更新日期:2020-04-21
中文翻译:
减肥手术作为2型糖尿病/代谢综合征的长期治疗。
与仅改变生活方式和药物治疗相比,代谢外科手术已日益被认为是2型糖尿病(T2D)和肥胖症患者的更有效治疗方法。观察性研究和临床试验均显示,代谢外科手术可导致持续的体重减轻(20-30%),T2D缓解率从23%到60%不等,并改善心血管疾病的危险因素,例如高血压和血脂异常。代谢外科手术具有成本效益且相对安全,围手术期的风险和死亡率可与低风险手术(如胆囊切除术,子宫切除术和阑尾切除术)相媲美。国际糖尿病和医疗组织已批准将代谢外科手术作为肥胖症T2D的标准治疗方法。